Simon M Collin

Summary

Affiliation: University of Bristol
Country: UK

Publications

  1. Rieu R, Chang C, Collin S, Fazekas J, Dassanaike S, Abbara A, et al. Time to detection in liquid culture of sputum in pulmonary MDR-TB does not predict culture conversion for early discharge. J Antimicrob Chemother. 2016;71:803-6 pubmed publisher
    ..TTD data from these pulmonary MDR-TB patients did not support a simple clinical prediction tool, but our analysis was limited by the small size of our sample. ..
  2. Collin S, Nikolaus S, Heron J, Knoop H, White P, Crawley E. Chronic fatigue syndrome (CFS) symptom-based phenotypes in two clinical cohorts of adult patients in the UK and The Netherlands. J Psychosom Res. 2016;81:14-23 pubmed publisher
    ..Future research needs to determine whether phenotypes predict treatment outcomes, and require different treatments. ..
  3. Collin S, Heron J, Nikolaus S, Knoop H, Crawley E. Chronic fatigue syndrome (CFS/ME) symptom-based phenotypes and 1-year treatment outcomes in two clinical cohorts of adult patients in the UK and The Netherlands. J Psychosom Res. 2018;104:29-34 pubmed publisher
    ..Adult CFS/ME patients with multiple symptoms or pain symptoms who present for specialist treatment are much less likely to report favourable treatment outcomes than patients who present with few symptoms. ..
  4. Collin S, Crawley E, May M, Sterne J, Hollingworth W. The impact of CFS/ME on employment and productivity in the UK: a cross-sectional study based on the CFS/ME national outcomes database. BMC Health Serv Res. 2011;11:217 pubmed publisher
    ..2 million. Sensitivity analyses suggested a range between £75.5-£128.9 million. CFS/ME incurs huge productivity costs amongst the small fraction of adults with CFS/ME who access specialist services. ..
  5. Collin S, Metcalfe C, Zuccolo L, Lewis S, Chen L, Cox A, et al. Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2009;18:2528-39 pubmed publisher
    ..Our meta-analysis suggests that known common folate-pathway single nucleotide polymorphisms do not have significant effects on susceptibility to prostate cancer. ..
  6. Collin S, Metcalfe C, Refsum H, Lewis S, Smith G, Cox A, et al. Associations of folate, vitamin B12, homocysteine, and folate-pathway polymorphisms with prostate-specific antigen velocity in men with localized prostate cancer. Cancer Epidemiol Biomarkers Prev. 2010;19:2833-8 pubmed publisher
    ..Long-term follow-up is needed to test associations with metastases and mortality, and the observed genetic effects require replication. ..
  7. Collin S, Bakken I, Nazareth I, Crawley E, White P. Health care resource use by patients before and after a diagnosis of chronic fatigue syndrome (CFS/ME): a clinical practice research datalink study. BMC Fam Pract. 2017;18:60 pubmed publisher
    ....
  8. Broughton J, Harris S, Beasant L, Crawley E, Collin S. Adult patients' experiences of NHS specialist services for chronic fatigue syndrome (CFS/ME): a qualitative study in England. BMC Health Serv Res. 2017;17:384 pubmed publisher
    ..This improvement came about through a process which included validation of patients' experiences, acceptance of change, practical advice and support, and therapeutic outcomes. ..
  9. Collin S, Crawley E. Specialist treatment of chronic fatigue syndrome/ME: a cohort study among adult patients in England. BMC Health Serv Res. 2017;17:488 pubmed publisher
    ....

Detail Information

Publications9

  1. Rieu R, Chang C, Collin S, Fazekas J, Dassanaike S, Abbara A, et al. Time to detection in liquid culture of sputum in pulmonary MDR-TB does not predict culture conversion for early discharge. J Antimicrob Chemother. 2016;71:803-6 pubmed publisher
    ..TTD data from these pulmonary MDR-TB patients did not support a simple clinical prediction tool, but our analysis was limited by the small size of our sample. ..
  2. Collin S, Nikolaus S, Heron J, Knoop H, White P, Crawley E. Chronic fatigue syndrome (CFS) symptom-based phenotypes in two clinical cohorts of adult patients in the UK and The Netherlands. J Psychosom Res. 2016;81:14-23 pubmed publisher
    ..Future research needs to determine whether phenotypes predict treatment outcomes, and require different treatments. ..
  3. Collin S, Heron J, Nikolaus S, Knoop H, Crawley E. Chronic fatigue syndrome (CFS/ME) symptom-based phenotypes and 1-year treatment outcomes in two clinical cohorts of adult patients in the UK and The Netherlands. J Psychosom Res. 2018;104:29-34 pubmed publisher
    ..Adult CFS/ME patients with multiple symptoms or pain symptoms who present for specialist treatment are much less likely to report favourable treatment outcomes than patients who present with few symptoms. ..
  4. Collin S, Crawley E, May M, Sterne J, Hollingworth W. The impact of CFS/ME on employment and productivity in the UK: a cross-sectional study based on the CFS/ME national outcomes database. BMC Health Serv Res. 2011;11:217 pubmed publisher
    ..2 million. Sensitivity analyses suggested a range between £75.5-£128.9 million. CFS/ME incurs huge productivity costs amongst the small fraction of adults with CFS/ME who access specialist services. ..
  5. Collin S, Metcalfe C, Zuccolo L, Lewis S, Chen L, Cox A, et al. Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2009;18:2528-39 pubmed publisher
    ..Our meta-analysis suggests that known common folate-pathway single nucleotide polymorphisms do not have significant effects on susceptibility to prostate cancer. ..
  6. Collin S, Metcalfe C, Refsum H, Lewis S, Smith G, Cox A, et al. Associations of folate, vitamin B12, homocysteine, and folate-pathway polymorphisms with prostate-specific antigen velocity in men with localized prostate cancer. Cancer Epidemiol Biomarkers Prev. 2010;19:2833-8 pubmed publisher
    ..Long-term follow-up is needed to test associations with metastases and mortality, and the observed genetic effects require replication. ..
  7. Collin S, Bakken I, Nazareth I, Crawley E, White P. Health care resource use by patients before and after a diagnosis of chronic fatigue syndrome (CFS/ME): a clinical practice research datalink study. BMC Fam Pract. 2017;18:60 pubmed publisher
    ....
  8. Broughton J, Harris S, Beasant L, Crawley E, Collin S. Adult patients' experiences of NHS specialist services for chronic fatigue syndrome (CFS/ME): a qualitative study in England. BMC Health Serv Res. 2017;17:384 pubmed publisher
    ..This improvement came about through a process which included validation of patients' experiences, acceptance of change, practical advice and support, and therapeutic outcomes. ..
  9. Collin S, Crawley E. Specialist treatment of chronic fatigue syndrome/ME: a cohort study among adult patients in England. BMC Health Serv Res. 2017;17:488 pubmed publisher
    ....